(Press-News.org) New research by RMIT University and Northern Health has examined Australia’s Long COVID services, guidelines and public health information, compared with international standards.
The researchers found Australia lacking in several categories, including early investigation, accessibility and availability of trustworthy public health information, and adequate multidisciplinary Long COVID services to meet demand.
Dean of RMIT’s School of Health and Biomedical Sciences and co-author on the paper, Professor Catherine Itsiopoulos, warned that this problem will only worsen over time.
“Long COVID is here to stay. As COVID-19 cases continue to accumulate, the cases of Long COVID will also increase,” said Itsiopoulos.
“With unclear diagnosis and unknown effective treatment, this new chronic disease will be highly costly to the individual and on public health systems worldwide.”
The true cost of Long COVID
The COVID-19 pandemic has resulted in an estimated 642 million cases since the outbreak, with more than 11 million confirmed cases in Australia.
In some cases, COVID-19 can develop into Long COVID. The Australian definition is when a person experiences symptoms for longer than 12 weeks after contracting COVID-19, while the US guidelines suggest four weeks.
“While most people recover fully, up to 40% of people experience lingering symptoms. Recent new data show that 14% of Victorians who had COVID-19 suffer from Long-COVID,” said Itsiopoulos.
“These symptoms can include fatigue, shortness of breath, persistent cough, joint pain, brain fog, cognitive dysfunction, anxiety, depression, loss of smell or taste and insomnia.
“Our study found that Long COVID patients have fallen through the cracks due to poor diagnosis, complex multiple chronic disease needs and poor access to health care.”
Confusion and undereducation – even among health professionals
The study compared Long COVID guidelines and services in Australia, and found significant gaps between what is recommended and what patients experience.
Co-lead author Associate Professor Zhen Zheng highlighted that while early investigation at week four after contracting COVID-19 is recommended by the Australian, UK and US guidelines, this is not consistently implemented in Australia.
“Because there’s so much confusion around the definition of Long COVID and so little that we know about it, even healthcare professions – including GPs at the frontlines of healthcare – don’t know how to spot the early signs or how best to help people experiencing it,” said Zheng.
The researchers also found trustworthy public health information on Long COVID – such as websites and webpages – are either not readily available or not advertised.
Where they exist, they are primarily written in English, disadvantaging people with low health literacy skills or from non-English speaking backgrounds.
Recommendations to improve Australia’s response
The researchers propose a Long COVID response built on US, UK and Australian guidelines which prioritises early investigation, also drawing on insights from the Australian National Strategic Framework for Chronic Conditions.
1) Early detection
Firstly, the researchers recommend that people with COVID-19 be monitored for Long COVID from four weeks after infection.
People with pre-existing conditions – like chronic fatigue, mental illness, arthritis or diabetes – should be warned they’re at higher risk of developing Long COVID and monitored for early for signs of the condition.
Zheng warned that detecting Long COVID is difficult, as 90% of cases develop from mild COVID-19.
“If patients are managing their COVID-19 at home, and not under the care of a GP, then it is difficult to detect early signs of Long COVID and implement prevention strategies,” said Zheng.
“This is why it is vital to educate the general public on Long COVID.”
Zheng said public health campaigns around vaccinations, hand hygiene, social distancing and mask wearing showed large-scale behavior-change was possible.
“Building on this success, we need to teach people how to best to look after themselves when they have COVID-19, facilitating recovery and monitoring for Long COVID symptoms through early consultation with their GP.”
2) Address mental health issues in the acute phase
One in three people experience depression or sleep problems, and up to one in two face anxiety, in the acute phase of COVID-19 and up to three months after infection.
The researchers warned that Australia needs better strategies to minimise the impact of mental health early – before the development of Long COVID.
3) Investigate symptoms at four to eight weeks
From four to eight weeks, GPs should investigate ongoing symptoms and encourage patients to make lifestyle changes aimed at reducing persistent inflammation, which is linked to Long COVID symptoms. Individuals may also begin seeing allied health professionals for help with symptoms like shortness of breath and fatigue.
4) Referral to a Long COVID clinic
If symptoms persist for more than eight weeks, people should be referred to a Long COVID clinic – and continue the above recommendations.
Long COVID clinics are already going under
Co-lead author, Dr Shiqi Luo, is among the researchers who identified 16 Long COVID services in Australia at the time of the research.
Since then, seven services have been created and three have been terminated. Victoria hosts nine of these services, all dedicated to providing multidisciplinary rehabilitation for Long COVID.
“Because Long COVID affects so many parts of the body in different ways, the best rehabilitation is multidisciplinary – which makes these clinics costly to operate and they can only accommodate a small number of Long COVID sufferers,” said Luo.
“In fact, three of the services in Victoria we looked at have already been terminated due to a lack of funding. We have insufficient Long COVID clinics to meet the demand.”
The study revealed there were no services specifically catering to children or elderly people, who may need different types of support – and two Victorian services even excluded aged care residents. There were no services in Australia available specifically to people with mental or physical disabilities.
Barriers to fighting Long COVID
Long COVID is a complex condition, with more than 50 symptoms affecting 10 different body systems, for a varied and unknown duration. It emerges as healthcare systems worldwide struggle to cope with the impacts of COVID-19’s continued presence.
Co-author on the study, Distinguished Professor Magdalena Plebanski, explained that while effective treatments are lacking, the right mix of supports and services have been shown to help.
“Specialists such as cardiologists, neurologists or immunologists can support recovery from specific circulatory, mental health or autoimmune complications,” said Plebanski.
“However, given the multiple organs affected in one person with Long COVID interact with each other, holistic integrative approaches are critical to patient recovery.”
Professor Don Campbell, Northern Health’s Clinical Service Director of the Staying Well Program and Medical Division Director of the Hospital Without Walls Program, said the study is timely and very helpful.
“Victoria held the first Long COVID conference on 1 September, convened by the Department of Health, which identified Long COVID rates of 14 per cent in a survey of over 11,000 respondents,” said Campbell.
“It’s now time for a coordinated response. Vulnerable marginalised community members are at particular risk. Research must focus on prevention and management of Long COVID.”
However, there are critical barriers that must be overcome – including health workforce training, improved public health education and funding for the implementation of multidisciplinary Long COVID services.
Support for the research
The RMIT Eat Move Heal project is supported by an RMIT Engaging Impact Platform fund, in collaboration with Northern Health, the Victorian Virtual Emergency Department, healthcare professionals, and Long COVID patients.
‘An Overview of Long COVID Support Services in Australia and International Clinical Guidelines, With a Proposed Care Model in a Global Context’ (DOI: 10.3389/phrs.2023.1606084) is published in Public Health Reviews.
END
New study reveals Australian Long COVID response lagging
2023-10-05
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Vaccine via the nasal passage could be the new line of defence against Strep A
2023-10-05
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Associate Professor Manisha Pandey, Professor Michael Good, and their team from Griffith University’s Institute for Glycomics, are leading the development of a Strep A vaccine which is currently in Phase 1 clinical trials in Canada and quickly advancing to Phase 2 efficacy trials.
The team’s new preclinical research, recently published in Nature Communications, shows an experimental liposome-based vaccine approach incorporating a conserved M-protein epitope from Strep A and an immunostimulatory glycolipid (3D(6-acyl) ...
Mays Cancer Center at UT Health San Antonio identifies possible markers for early metastatic lung cancer
2023-10-05
SAN ANTONIO, Oct. 5, 2023 – Researchers at Mays Cancer Center at The University of Texas Health Science at San Antonio (UT Health San Antonio) have identified protein markers that could signal for early development of metastatic lung cancer, providing possibilities for new treatment.
The findings already have led to a five-year, $1.6 million grant from the National Cancer Institute of the National Institutes of Health that will pave the way for a clinical trial next year for patients with advanced lung cancer. The research is detailed in a new article in Cell Reports, ...
WHO director praises London’s ULEZ expansion as politically courageous
2023-10-05
London mayor Sadiq Khan’s efforts to expand the capital’s Ultra Low Emission Zone (ULEZ) as part of a push to reduce air pollution and improve health, is politically courageous and an example for mayors around the world, says the World Health Organization’s environment, climate change and health director, Maria Neira.
In an exclusive interview for The BMJ’s climate issue, Neira says she is tired of listening to politicians speak on climate change as if they didn't have the power to ...
Software can detect hidden and complex emotions in parents
2023-10-05
Researchers have conducted trials using a software capable of detecting intricate details of emotions that remain hidden to the human eye.
The software, which uses an ‘artificial net’ to map key features of the face, can evaluate the intensities of multiple different facial expressions simultaneously.
The University of Bristol and Manchester Metropolitan University team worked with Bristol’s Children of the 90s study participants to see how well computational methods could capture authentic human emotions amidst everyday ...
$2 million grant boosts technological advancements in cutting-edge cell therapy manufacturing facility
2023-10-05
The Keck School of Medicine of USC has received $2 million from the California Institute of Regenerative Medicine (CIRM) to further augment its newly launched cGMP Laboratory, a state-of-the-art facility designed to advance early-stage research into clinically viable cell and gene therapies. To expedite the translation of these therapies from the lab to the clinic, the facility needs advanced technological know-how, streamlined operations and strict protocols for developing and testing these products, all of which ...
Texas Children’s Bariatric Surgery Program receives prestigious national accreditation
2023-10-05
HOUSTON (October 4, 2023) – Texas Children’s Hospital is proud to announce that its Adolescent Bariatric Surgery Program has received national accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP).
Texas Children’s Hospital The Woodlands is the only Bariatric Surgery Center in the state of Texas that serves to an adolescent-only patient population with a multidisciplinary clinical staff who is certified to meet the surgical, medical and psychological needs of ...
Two-dimensional compounds can capture carbon from the air
2023-10-05
Some of the thinnest materials known to mankind may provide solutions to scientists in their quest to curb the effects of global warming.
Known as MXene and MBene compounds, these substances are only a few atoms thick, making them two-dimensional. Because of their large surface area, the materials have the potential to absorb carbon dioxide molecules from the atmosphere, which could help reduce the harmful effects of climate change by safely sequestering carbon dioxide.
In a paper published Oct. 4 in the journal Chem, UC Riverside professor Mihri Ozkan and her co-authors explain the potential of MXenes and MBenes in carbon capture technologies.
“In this review, ...
New type of tiny wasp comes with mysterious, cloud-like structures at ends of antennae
2023-10-05
CORVALLIS, Ore. – Fossil researchers have discovered a novel genus and species of tiny wasp with a mysterious, bulbous structure at the end of each antenna.
The female micro-wasp was described from 100-million-year-old Burmese amber in a study led by George Poinar Jr., who holds a courtesy appointment in the Oregon State University College of Science.
Poinar and Fernando Vega, an independent researcher based in Silver Spring, Maryland, have some ideas about the “clouds” on the ...
Tirzepatide is as effective at treating early-onset type 2 diabetes as diabetes diagnosed later in life
2023-10-05
Tirzepatide is as effective at treating early-onset type 2 diabetes (T2D), a more aggressive form of the condition that normally responds less well to treatment, as it is at treating T2D diagnosed later in life, new research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found.
Tirzepatide belongs to a new class of drugs that mimic the effect of two hormones involved in blood sugar control and appetite suppression, ...
Commonly prescribed antibiotic, antipsychotic and prokinetic drugs are associated with a higher risk of sudden cardiac arrest (SCA) in people with type 2 diabetes, study finds
2023-10-05
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has identified a range of characteristics associated with a higher risk of sudden cardiac arrest in individuals with type 2 diabetes.
These include the some commonly prescribed antibiotic and antipsychotic drugs, prokinetics (drugs used to treat gastrointestinal symptoms such as nausea and vomiting) and low fasting blood sugar.
Sudden cardiac arrest (SCA) is a leading cause of death. ...